WILEX Company
WILEX is a biopharmaceutical company developing drugs and diagnostic agents to detect and treat malignant tumors and cancers.
Technology:
Atrificial Vectors and Immune Cells
Headquarters:
Ladenburg, Baden-Wurttemberg, Germany
Founded Date:
1997-01-01
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
4
Total Funding:
5120000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2010-03-23
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership